GLP-1 Drugs May Lower Cancer Risk

New research suggests GLP-1 drugs like Ozempic, used for diabetes and weight loss, may also slash cancer risk—by up to 30% in breast cancer cases and showing promise for colorectal and lung cancers too. Scientists believe the drugs might be doing more than just helping people shed pounds: they could be calming systemic inflammation, a known cancer fuel. While observational studies are exciting, experts stress it’s too early to say these drugs prevent cancer—rigorous trials are needed to confirm cause and effect and uncover how exactly they might be working. Not a cure yet, but a thrilling new frontier in cancer prevention science. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/71ff7d861a998839